Trial site
Hutchinson Regional Medical Center
Hutchinson, Kansas 67502, United StatesNot linked to an institution yet
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Lead sponsor
- National Cancer Institute (NCI)10 trials
- SWOG Cancer Research Network1 trial
Running trials
Active, not recruiting
S0820, Adenoma and Second Primary Prevention Trial
NCT01349881· Phase 3· SWOG Cancer Research Network· Source
Active, not recruiting
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
NCT00972478· Phase 1/2· National Cancer Institute (NCI)· Source
Active, not recruiting
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
NCT00792948· Phase 2· National Cancer Institute (NCI)· Source
Active, not recruiting
Dinaciclib in Treating Patients With Stage IV Melanoma
NCT00937937· Phase 2· National Cancer Institute (NCI)· Source
Active, not recruiting
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
NCT00569127· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT00334815· Phase 2· National Cancer Institute (NCI)· Source
Report an error